0001345281-21-000003.txt : 20211103
0001345281-21-000003.hdr.sgml : 20211103
20211103185150
ACCESSION NUMBER: 0001345281-21-000003
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211103
FILED AS OF DATE: 20211103
DATE AS OF CHANGE: 20211103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FRIEDMAN ERIC J
CENTRAL INDEX KEY: 0001216280
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31668
FILM NUMBER: 211377119
MAIL ADDRESS:
STREET 1: C/O INTEGRATED HEAITH TECHNOLOGIES INC
STREET 2: 201 RT 22
CITY: HILLSIDE
STATE: NJ
ZIP: 07205
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INTEGRATED BIOPHARMA INC
CENTRAL INDEX KEY: 0001016504
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 222407475
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 225 LONG AVENUE
STREET 2: BUILDING 15
CITY: HILLSIDE
STATE: NJ
ZIP: 07205
BUSINESS PHONE: 9739260816
MAIL ADDRESS:
STREET 1: 225 LONG AVENUE
STREET 2: BUILDING 15
CITY: HILLSIDE
STATE: NJ
ZIP: 07205
FORMER COMPANY:
FORMER CONFORMED NAME: INTEGRATED HEALTH TECHNOLOGIES INC
DATE OF NAME CHANGE: 20020912
FORMER COMPANY:
FORMER CONFORMED NAME: CHEM INTERNATIONAL INC
DATE OF NAME CHANGE: 19960716
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2021-11-03
0
0001016504
INTEGRATED BIOPHARMA INC
inbp
0001216280
FRIEDMAN ERIC J
C/O INTEGRATED HEAITH TECHNOLOGIES INC
201 RT 22
HILLSIDE
NJ
07205
1
0
0
0
Stock Option (right to buy)
2021-11-03
4
A
0
50000
0
A
2031-11-03
Common Stock
50000
50000
D
The Exercise Price of the Stock Option will be the closing prices of the Issuer's Common Stock five trading days after the filing of the Issuer's Quarterly Report on Form 10-Q for the period ended September 30, 2021, with the Securities and Exchange Commission(the "Issue Date").
The option vests and becomes exercisable as follows: 25% (12,500 shares) on the Issue Date, 25% (12,500 shares) on December 31, 2021, 25% (12,500 shares) on March 31, 2022 and 25% (12,500 shares) on June 30, 2022.
/s/Eric J Friedman
2021-11-03